It is important not to freeze the solution, as this can negatively affect the peptides structure and efficacy
What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect

$79/first month Applies to 3-month plan billed in full ($149/mo after) Whats included Personalized, clinician-guided plan Monthly and 3-month plans Dispensed by US-licensed compounding pharmacy Unlimited protocol adjustments and messaging Ongoing support and check-ins Pause or cancel anytime Backed by our in-house Stanford PhD-led team Get Started Made for your biology No two people age the same way, so no two treatments are exactly the same
Safety Considerations There are currently no published studies specifically examining the combination of 5-amino-1MQ and Tirzepatide in humans
In case of any unexpected effect, consult your healthcare professional as soon as possible